Teleflex Announces Third Quarter 2025 Earnings Conference Call Information And Vascular Intervention Investor Virtual Meeting Details

2025-10-16 04:45:55

(MENAFN- GlobeNewsWire - Nasdaq) WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025.

To participate in the conference call, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website, teleflex.

An audio replay of the call will be available beginning at 11:00 am Eastern Time on November 6, 2025, either on the Teleflex website or by telephone. The call can be accessed by dialing 1 800 770 2030 (U.S. and Canada) or 1 609 800 9909 (all other locations). The conference ID is 69028.

Vascular Intervention Virtual Meeting

On November 14, 2025, at 8:00 am Eastern Time, Teleflex will host a virtual meeting to review its recent Vascular Intervention business acquisition, with a focus on the strategic rationale and the comprehensive coronary and peripheral product portfolio.

To participate in the investor event, please utilize this link to pre-register and receive the dial-in information. The call can also be accessed through a live audio webcast on the company's website,.

About Teleflex Incorporated

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.

Teleflex is the home of ArrowTM, BarrigelTM, DeknatelTM, LMATM, PillingTM, QuikClotTM RüschTM, UroLiftTM and WeckTM – trusted brands united by a common sense of purpose.

At Teleflex, we are empowering the future of healthcare. For more information, please visit.

Contacts:
Teleflex Incorporated:
Lawrence Keusch
Vice President, Investor Relations and Strategy Development

610-948-2836

MENAFN16102025004107003653ID1110208536

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.